AR048827A1 - Aparato y metodo para la administracion transdermica de agentes basados en fentanil - Google Patents
Aparato y metodo para la administracion transdermica de agentes basados en fentanilInfo
- Publication number
- AR048827A1 AR048827A1 ARP050101446A ARP050101446A AR048827A1 AR 048827 A1 AR048827 A1 AR 048827A1 AR P050101446 A ARP050101446 A AR P050101446A AR P050101446 A ARP050101446 A AR P050101446A AR 048827 A1 AR048827 A1 AR 048827A1
- Authority
- AR
- Argentina
- Prior art keywords
- fentanyl
- microprojections
- transdermal administration
- fentanil
- based agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un aparato y un método para la administracion por vía transdérmica de un agente biologicamente activo, basados en fentanil, que comprende un sistema de administracion que posee un miembro ( o sistema) con microproyecciones que incluye una pluralidad de microproyecciones (o un arreglo de las mismas) adaptadas paraperforar el estrato corneo e ingresar a la capa epidérmica o a las capas epidérmica y dérmica. En una realizacion, el agente basado en fentanil está contenido en un recubrimiento biocompatible que se aplica al miembro con microproyecciones En una realizacion adicional, el sistema de administracion incluye un pack de gel que posee una formulacion de hidrogel que contiene un agente basado en fentanil que se dispone sobre el miembro microproyecciones después de la aplicacion a la piel de un paciente. En una realizacion adicional, el agente basado en fentanil está contenido tanto en el recubrimiento como en la formulacion de hidrogel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56194904P | 2004-04-13 | 2004-04-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR048827A1 true AR048827A1 (es) | 2006-05-31 |
Family
ID=35197490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050101446A AR048827A1 (es) | 2004-04-13 | 2005-04-13 | Aparato y metodo para la administracion transdermica de agentes basados en fentanil |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050226922A1 (es) |
EP (1) | EP1737434A2 (es) |
JP (1) | JP2007532645A (es) |
KR (1) | KR20070011469A (es) |
CN (1) | CN101027045A (es) |
AR (1) | AR048827A1 (es) |
AU (1) | AU2005235075A1 (es) |
BR (1) | BRPI0509901A (es) |
CA (1) | CA2562731A1 (es) |
MX (1) | MXPA06011972A (es) |
TW (1) | TW200602099A (es) |
WO (1) | WO2005102334A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2656860T3 (da) | 2005-06-17 | 2021-07-26 | Wisconsin Alumni Res Found | Topikale vasokonstriktorpræparater og fremgangsmåder til beskyttelse af celler under cancer kemoterapi og strålingsterapi |
AU2012202731B2 (en) * | 2005-06-17 | 2014-06-19 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
AU2014202738B2 (en) * | 2005-06-17 | 2016-05-12 | Wisconsin Alumni Research Foundation | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
BRPI0620671A2 (pt) * | 2005-12-14 | 2011-11-22 | Ariana Holdings Pty Ltd | dispositivo para aplicar um composto quìmico e método de aplicação de um composto quìmico |
WO2007127815A2 (en) * | 2006-04-25 | 2007-11-08 | Alza Corporation | Microprojection array application with multilayered microprojection member for high drug loading |
WO2007127811A2 (en) * | 2006-04-25 | 2007-11-08 | Alza Corporation | Microprojection array application with grouped microprojections for high drug loading |
US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
HUP0700828A2 (en) * | 2007-12-20 | 2010-01-28 | Richter Gedeon Nyrt | Transdermal pharmaceutical compositions containing tolperisone alone and in combination |
US20110237614A1 (en) * | 2008-09-16 | 2011-09-29 | Nektar Therapeutics | Pegylated Opioids with Low Potential for Abuse |
US8894630B2 (en) | 2009-11-13 | 2014-11-25 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
US8888761B2 (en) | 2009-11-13 | 2014-11-18 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
US8439896B2 (en) * | 2009-11-13 | 2013-05-14 | The Invention Science Fund I, Llc | Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
WO2011096468A1 (ja) | 2010-02-05 | 2011-08-11 | 株式会社ニチレイバイオサイエンス | 免疫組織化学染色用前処理液及びその濃縮液 |
CN105815785A (zh) * | 2016-03-31 | 2016-08-03 | 常州大学 | 一种从黄瓜中提取丙醇二酸制备除脂粉的方法 |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
CN110536861B (zh) | 2017-04-18 | 2023-07-04 | 突破技术有限责任公司 | 硫的生产 |
EP3723725B1 (de) * | 2017-12-14 | 2022-02-02 | LTS LOHMANN Therapie-Systeme AG | Mikronadelarray aufweisend einen wirkstoff in form von salzen |
CN108318646A (zh) * | 2018-03-27 | 2018-07-24 | 苏州桓晨医疗科技有限公司 | 一种模拟药物体外释放的释放介质 |
EP4138903A4 (en) * | 2020-04-22 | 2023-12-13 | Emergex USA Corporation | TRANSDERMAL DRUG RELEASE DEVICE WITH CORONAVIRUS VACCINE-COATED MICROPROJECTIONS |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
BE795384A (fr) * | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
US4486423A (en) * | 1983-04-21 | 1984-12-04 | Janssen Pharmaceutica Inc. | Stable fentanyl composition |
US5080646A (en) * | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5169382A (en) * | 1988-10-03 | 1992-12-08 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5147296A (en) * | 1988-10-03 | 1992-09-15 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
WO1996037155A1 (en) * | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical device and method for enhancing delivery of compounds through the skin |
US6143037A (en) * | 1996-06-12 | 2000-11-07 | The Regents Of The University Of Michigan | Compositions and methods for coating medical devices |
US5916524A (en) * | 1997-07-23 | 1999-06-29 | Bio-Dot, Inc. | Dispensing apparatus having improved dynamic range |
US5741554A (en) * | 1996-07-26 | 1998-04-21 | Bio Dot, Inc. | Method of dispensing a liquid reagent |
US5738728A (en) * | 1996-07-26 | 1998-04-14 | Bio Dot, Inc. | Precision metered aerosol dispensing apparatus |
US5743960A (en) * | 1996-07-26 | 1998-04-28 | Bio-Dot, Inc. | Precision metered solenoid valve dispenser |
KR100561892B1 (ko) * | 1997-12-11 | 2006-03-16 | 알자 코포레이션 | 경피성 작용제 유동률을 증진시키기 위한 장치 |
US6050988A (en) * | 1997-12-11 | 2000-04-18 | Alza Corporation | Device for enhancing transdermal agent flux |
US6091975A (en) * | 1998-04-01 | 2000-07-18 | Alza Corporation | Minimally invasive detecting device |
JP4205778B2 (ja) * | 1998-04-17 | 2009-01-07 | 久光製薬株式会社 | 貼付製剤 |
EP1169025B1 (en) * | 1999-04-01 | 2005-08-24 | Alza Corporation | Transdermal drug delivery devices comprising a polyurethane drug reservoir |
US6250023B1 (en) * | 1999-10-19 | 2001-06-26 | Bruce A. Donoho | Preventive device against nuisance from birds |
WO2001064149A1 (en) * | 2000-02-29 | 2001-09-07 | Jie Zhang | Improved transdermal drug patch |
JP5507030B2 (ja) * | 2000-09-08 | 2014-05-28 | アルザ・コーポレーシヨン | 経路閉鎖を阻害することによる経皮的薬物流動の減少の抑制方法 |
US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
MXPA03003303A (es) * | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Retenedor del miembro de microprotrusion para aplicador de impacto. |
US6855372B2 (en) * | 2001-03-16 | 2005-02-15 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
EP1392389B1 (en) * | 2001-04-20 | 2009-10-07 | Alza Corporation | Microprojection array having a beneficial agent containing coating |
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US7790215B2 (en) * | 2002-03-26 | 2010-09-07 | Purdue Pharma Lp | Sustained-release gel coated compositions |
-
2005
- 2005-03-18 MX MXPA06011972A patent/MXPA06011972A/es not_active Application Discontinuation
- 2005-03-18 WO PCT/US2005/009153 patent/WO2005102334A2/en active Application Filing
- 2005-03-18 EP EP05725916A patent/EP1737434A2/en not_active Withdrawn
- 2005-03-18 KR KR1020067023557A patent/KR20070011469A/ko not_active Application Discontinuation
- 2005-03-18 BR BRPI0509901-3A patent/BRPI0509901A/pt not_active Application Discontinuation
- 2005-03-18 US US11/084,636 patent/US20050226922A1/en not_active Abandoned
- 2005-03-18 JP JP2007508360A patent/JP2007532645A/ja active Pending
- 2005-03-18 AU AU2005235075A patent/AU2005235075A1/en not_active Abandoned
- 2005-03-18 CN CNA2005800190170A patent/CN101027045A/zh active Pending
- 2005-03-18 CA CA002562731A patent/CA2562731A1/en not_active Abandoned
- 2005-04-12 TW TW094111541A patent/TW200602099A/zh unknown
- 2005-04-13 AR ARP050101446A patent/AR048827A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007532645A (ja) | 2007-11-15 |
BRPI0509901A (pt) | 2007-08-07 |
EP1737434A2 (en) | 2007-01-03 |
TW200602099A (en) | 2006-01-16 |
MXPA06011972A (es) | 2007-04-16 |
WO2005102334A2 (en) | 2005-11-03 |
CA2562731A1 (en) | 2005-11-03 |
AU2005235075A1 (en) | 2005-11-03 |
CN101027045A (zh) | 2007-08-29 |
US20050226922A1 (en) | 2005-10-13 |
KR20070011469A (ko) | 2007-01-24 |
WO2005102334A3 (en) | 2006-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR048827A1 (es) | Aparato y metodo para la administracion transdermica de agentes basados en fentanil | |
AR046697A1 (es) | Metodo y sistema de administracion transdermica de agente asistido por frecuencia | |
AR046823A1 (es) | Sistema y metodo de administracion de vacuna transdermica asistida por ultrasonido | |
BRPI0415466A (pt) | método e sistema de pré-tratamento para intensificar a distribuição transdérmica de fármacos | |
TW200618830A (en) | Micorprojection apparatus and system with low infection potential | |
BRPI0509788A (pt) | aparato e método para liberação transdérmica de agentes de hormÈnio paratireóides | |
BRPI0509493A (pt) | aparelho e método para a liberação transdérmica de vacina da influenza | |
ES2687258T3 (es) | Procedimiento de fabricación de conjuntos de microagujas | |
CN102657914B (zh) | 高渗透效率的微针透皮输入贴 | |
EP2001453A4 (en) | APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF PARATHYROID HORMONE AGENTS FOR TREATING OR PREVENTING OSTEOPENIA | |
CA2618033C (en) | Transdermal drug delivery device comprising extensor-relaxor means | |
BR0312671A (pt) | Dispositivo de microagulhas, método para utilizar um dispositivo de microagulhas, e, método para aplicar um dispositivo de microagulhas | |
BRPI0517501A (pt) | dispositivo médico apropriado para uso na administração de um componente ativo na ou através da pele | |
TW200616660A (en) | Apparatus and method for transdermal delivery of natriuretic peptides | |
AR064268A1 (es) | Sistema terapeutico transdermico para administracion del principio activo buprenorfina | |
BRPI0416132A (pt) | sistema e método para liberação de vacina transdérmica | |
BRPI0417437A (pt) | dispositivo para inibição da absorção, dispositivo para remoção de agente fisiologicamente ativo e dispositivo para redução do efeito de overdose | |
BRPI0411032A (pt) | composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica | |
BRPI0415986A (pt) | método e aparelho para reduzir a incidência do uso de tabaco | |
AR050608A1 (es) | Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular | |
AR054225A1 (es) | Aparato y metodo para suministro transdermico de agentes basados en epoyetina | |
TW200602019A (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents | |
KR20190127235A (ko) | 미용액의 전달성이 향상된 니들 패치 | |
DOP2003000759A (es) | Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |